First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline

Published:2016-06-10 Issue:3 Volume:48 Page:935-938
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Tadolini Marina,Lingtsang Rangjung Dolma,Tiberi Simon,Enwerem Martin,D'Ambrosio Lia,Sadutshang Tsetan Dorji,Centis Rosella,Migliori Giovanni Battista

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference15 articles.

1. Tuberculosis elimination, patients' lives and rational use of new drugs: revisited

2. Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence

3. Delamanid (OPC-67683) for treatment of multi-drug-resistant tuberculosis

4. Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid

5. ERS/WHO Tuberculosis Consilium assistance with extensively drug-resistant tuberculosis management in a child: case study of compassionate delamanid use

Cited by 106 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of effectiveness and safety of delamanid-containing regimens using individual patient datasets;The International Journal of Tuberculosis and Lung Disease;2024-09-01

2. A Narrative Review of Bedaquiline and Delamanid: New Arsenals Against Multidrug‐Resistant and Extensively Drug‐Resistant Mycobacterium tuberculosis;Journal of Clinical Laboratory Analysis;2024-08

3. QT-Interval Prolongation in the Treatment of Drug-Resistant Tuberculosis;Antibiot Khimioter = Antibiotics and Chemotherapy;2024-03-27

4. Delamanid: Safety and Efficacy Analysis;Tuberculosis and Lung Diseases;2023-12-25

5. Impact of Prior TB Treatment With New/Companion Drugs on Clinical Outcomes in Patients Receiving Concomitant Bedaquiline and Delamanid for MDR/RR-TB;Clinical Infectious Diseases;2023-11-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3